Exact Mass: 317.2593

Exact Mass Matches: 317.2593

Found 152 metabolites which its exact mass value is equals to given mass value 317.2593, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

4-Hydroxysphinganine

[2S-(2R*,3R*,4S*)]-2-amino-1,3,4-octadecanetriol

C18H39NO3 (317.293)


Phytosphingosine is a phospholipid. Phospholipids are a class of lipids and a major component of all biological membranes; sphingolipid metabolites, such as sphingosine and ceramide, are highly bioactive compounds and are involved in diverse cell processes, including cell-cell interaction, cell proliferation, differentiation, and apoptosis. Phytosphingosine is also one of the most widely distributed natural sphingoid bases, which is abundant in fungi and plants, and also found in animals including humans. Phytosphingosine is structurally similar to sphingosine; phytosphingosine possesses a hydroxyl group at C-4 of the sphingoid long-chain base. The physiological roles of phytosphingosine are largely unknown. Phytosphingosine induces apoptosis in human T-cell lymphoma and non-small cell lung cancer cells, and induces caspase-independent cytochrome c release from mitochondria. In the presence of caspase inhibitors, phytosphingosine-induced apoptosis is almost completely suppressed, suggesting that phytosphingosine-induced apoptosis is largely dependent on caspase activities. (PMID: 12576463, 12531554, 8046331, 8048941,8706124) [HMDB] Phytosphingosine is a phospholipid. Phospholipids are a class of lipids and a major component of all biological membranes; sphingolipid metabolites, such as sphingosine and ceramide, are highly bioactive compounds and are involved in diverse cell processes, including cell-cell interaction, cell proliferation, differentiation, and apoptosis. Phytosphingosine is also one of the most widely distributed natural sphingoid bases, which is abundant in fungi and plants, and also found in animals including humans. Phytosphingosine is structurally similar to sphingosine; phytosphingosine possesses a hydroxyl group at C-4 of the sphingoid long-chain base. The physiological roles of phytosphingosine are largely unknown. Phytosphingosine induces apoptosis in human T-cell lymphoma and non-small cell lung cancer cells, and induces caspase-independent cytochrome c release from mitochondria. In the presence of caspase inhibitors, phytosphingosine-induced apoptosis is almost completely suppressed, suggesting that phytosphingosine-induced apoptosis is largely dependent on caspase activities. (PMID: 12576463, 12531554, 8046331, 8048941,8706124). Phytosphingosine is a?phospholipid and has anti-cancer activities. Phytosphingosine induces cell apoptosis via caspase 8 activation and Bax translocation in cancer cells[1].

   

18-Epiormosanine

18-Epiormosanine

C20H35N3 (317.2831)


   

HEXOCYCLIUM

HEXOCYCLIUM

C20H33N2O+ (317.2593)


A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AB - Synthetic anticholinergics, quaternary ammonium compounds C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent

   

Butenafine

N-4-Tert-butylbenzyl-N-methyl-1-naphthalene methylamine hydrochloride

C23H27N (317.2143)


Butenafine is only found in individuals that have used or taken this drug. It is a synthetic benzylamine antifungal agent.Although the mechanism of action has not been fully established, it has been suggested that butenafine, like allylamines, interferes with sterol biosynthesis (especially ergosterol) by inhibiting squalene monooxygenase, an enzyme responsible for converting squalene to 2,3-oxydo squalene. As ergosterol is an essential component of the fungal cell membrane, inhibition of its synthesis results in increased cellular permeability causing leakage of cellular contents. Blockage of squalene monooxygenase also leads to a subsequent accumulation of squalene. When a high concentration of squalene is reached, it is thought to have an effect of directly kill fungal cells. D - Dermatologicals > D01 - Antifungals for dermatological use > D01A - Antifungals for topical use D000890 - Anti-Infective Agents > D000935 - Antifungal Agents C254 - Anti-Infective Agent > C514 - Antifungal Agent

   

Funtumine

3alpha-amino-5alpha-pregnan-20-one

C21H35NO (317.2719)


   

MLS002608010

17beta-Hydroxy-4,17-dimethyl-4-azaandrost-5-en-3-one

C20H31NO2 (317.2355)


   

Piptanthine

Piptanthine

C20H35N3 (317.2831)


Origin: Plant; SubCategory_DNP: Alkaloids derived from lysine, Piperidine alkaloids

   
   

3-hydroxynonanoyl carnitine

3-[(3-hydroxynonanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C16H31NO5 (317.2202)


3-Hydroxynonanoyl carnitine is an acylcarnitine. More specifically, it is an 3-hydroxynonanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy.  This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 3-Hydroxynonanoyl carnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 3-hydroxynonanoyl carnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Morpholine, 4-(3-(4-(1,1-dimethylpropyl)phenyl)-2-methylpropyl)-2,6-dimethyl-

Morpholine, 4-(3-(4-(1,1-dimethylpropyl)phenyl)-2-methylpropyl)-2,6-dimethyl-

C21H35NO (317.2719)


D000890 - Anti-Infective Agents > D000935 - Antifungal Agents

   

4-hydroxysphinganine

2-Amino-1,3,4-octadecanetriol

C18H39NO3 (317.293)


4-hydroxysphinganine is a member of the class of compounds known as 1,3-aminoalcohols. 1,3-aminoalcohols are organic compounds containing an alkyl chain with an amine group bound to the C1 atom and an alcohol group bound to the C3 atom. 4-hydroxysphinganine is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). 4-hydroxysphinganine can be found in a number of food items such as fenugreek, citrus, chestnut, and boysenberry, which makes 4-hydroxysphinganine a potential biomarker for the consumption of these food products.

   
   

Wrightiamine B

Wrightiamine B

C21H35NO (317.2719)


   

drofenine

drofenine

C20H31NO2 (317.2355)


C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent C78272 - Agent Affecting Nervous System > C29698 - Antispasmodic Agent

   

(2E,4E,9Z)-1-(piperidin-1-yl)hexadeca-2,4,9-trien-1-one

(2E,4E,9Z)-1-(piperidin-1-yl)hexadeca-2,4,9-trien-1-one

C21H35NO (317.2719)


   
   

Holafebrine

Holafebrine

C21H35NO (317.2719)


   
   
   

1-(1,2,3,4,5,6,7,10-octahydro-4,4,10-trimethyl-8H-benzo[e]indol-2-yl)-3-hydroxy-3-methylbutan-2-one|chamobtusin A

1-(1,2,3,4,5,6,7,10-octahydro-4,4,10-trimethyl-8H-benzo[e]indol-2-yl)-3-hydroxy-3-methylbutan-2-one|chamobtusin A

C20H31NO2 (317.2355)


   

cavernene B

cavernene B

C21H35NO (317.2719)


   

mycalazal-16

mycalazal-16

C21H35NO (317.2719)


   

(7aS,11aS,11bS)-7,7a,8,9,10,11,11a,11b-octahydro-11b-hydroxy-alpha,alpha,8,8,11a-pentamethyl-6H-naphth[1,2-d]azepine-4-methanol|triptotin J

(7aS,11aS,11bS)-7,7a,8,9,10,11,11a,11b-octahydro-11b-hydroxy-alpha,alpha,8,8,11a-pentamethyl-6H-naphth[1,2-d]azepine-4-methanol|triptotin J

C20H31NO2 (317.2355)


   

1-Methyl-2-[9-(2-methoxyphenyl)nonyl]pyrrolidine

1-Methyl-2-[9-(2-methoxyphenyl)nonyl]pyrrolidine

C21H35NO (317.2719)


   

batzellaside B

batzellaside B

C17H35NO4 (317.2566)


   

DTXSID00694029

DTXSID00694029

C21H35NO (317.2719)


   

2-benzyl-1-methyl-5-nonylpyrrolidin-3-ol

NCGC00385689-01!2-benzyl-1-methyl-5-nonylpyrrolidin-3-ol

C21H35NO (317.2719)


   

Phytosphingosine

4-hydroxysphinganine (SaccharoMyces Cerevisiae)

C18H39NO3 (317.293)


Phytosphingosine is a?phospholipid and has anti-cancer activities. Phytosphingosine induces cell apoptosis via caspase 8 activation and Bax translocation in cancer cells[1].

   

Ormosanine

Ormosanine

C20H35N3 (317.2831)


Annotation level-1

   

Phytosphingosine (not validated, isomer of 1697)

Phytosphingosine (not validated, isomer of 1697)

C18H39NO3 (317.293)


Annotation level-2

   

Phytosphingosine (not validated, isomer of 1696)

Phytosphingosine (not validated, isomer of 1696)

C18H39NO3 (317.293)


Annotation level-2

   

1-((2R)(2-piperidyl))(1S,10S,2R)-3,15-diazatetracyclo(7.7.1.0(2,7).0(10,15))heptadecane

1-((2R)(2-piperidyl))(1S,10S,2R)-3,15-diazatetracyclo(7.7.1.0(2,7).0(10,15))heptadecane

C20H35N3 (317.2831)


Origin: Plant; Formula(Parent): C20H35N3; Bottle Name:Ormosanine; PRIME Parent Name:Ormosanine; PRIME in-house No.:V0309; SubCategory_DNP: Alkaloids derived from lysine, More complex lysine-derived alkaloids, Ormosia alkaloids

   

D-Ribo-phytosphingosine

D-Ribo-phytosphingosine

C18H39NO3 (317.293)


   

Trihexyphenidyl N-oxide

Trihexyphenidyl N-oxide

C20H31NO2 (317.2355)


   

Hydroxytrihexyphenidyl

Hydroxytrihexyphenidyl

C20H31NO2 (317.2355)


   

N-methyl arachidonoylamide

N-methyl-5Z,8Z,11Z,14Z-eicosatetraenoyl amine

C21H35NO (317.2719)


   

N-phenethyltridecanamide

N-phenethyltridecanamide

C21H35NO (317.2719)


   
   

Amorolfine

Amorolfine

C21H35NO (317.2719)


D - Dermatologicals > D01 - Antifungals for dermatological use > D01A - Antifungals for topical use D000890 - Anti-Infective Agents > D000935 - Antifungal Agents

   

NA 21:4

N-methyl-5Z,8Z,11Z,14Z-eicosatetraenoyl amine

C21H35NO (317.2719)


   
   

Amorolfine hydrochloride

Amorolfine hydrochloride

C21H35NO (317.2719)


   

4-METHYL-3-PYRROLIDIN-1-YLMETHYL-PIPERAZINE-1-CARBOXYLICACIDBENZYLESTER

4-METHYL-3-PYRROLIDIN-1-YLMETHYL-PIPERAZINE-1-CARBOXYLICACIDBENZYLESTER

C18H27N3O2 (317.2103)


   

N,N-dioctylaniline

N,N-dioctylaniline

C22H39N (317.3082)


   

2,2-[2-(dodecyloxy)ethyl]imino]bisethanol

2,2-[2-(dodecyloxy)ethyl]imino]bisethanol

C18H39NO3 (317.293)


   

4-(4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENETHYL)MORPHOLINE

4-(4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENETHYL)MORPHOLINE

C18H28BNO3 (317.2162)


   

1-ETHYL-4-(5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDIN-2-YL)PIPERAZINE

1-ETHYL-4-(5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDIN-2-YL)PIPERAZINE

C17H28BN3O2 (317.2274)


   

N-cyclohexyl-2-nitro-4-((piperidin-1-yl)methyl)benzenamine

N-cyclohexyl-2-nitro-4-((piperidin-1-yl)methyl)benzenamine

C18H27N3O2 (317.2103)


   

N,N-diethyl-2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]acetamide

N,N-diethyl-2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]acetamide

C18H28BNO3 (317.2162)


   

N-tert-Butyl-2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetamide

N-tert-Butyl-2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetamide

C18H28BNO3 (317.2162)


   

Dicyclohexyl(4-(N,N-dimethylamino)phenyl)phosphine

Dicyclohexyl(4-(N,N-dimethylamino)phenyl)phosphine

C20H32NP (317.2272)


   

4-hexadecylanilin

4-hexadecylanilin

C22H39N (317.3082)


   

methyl methyl undecylidene aminobenzoate

methyl methyl undecylidene aminobenzoate

C20H31NO2 (317.2355)


   

N,N-DIETHYL-2-(4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)ACETAMIDE

N,N-DIETHYL-2-(4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)ACETAMIDE

C18H28BNO3 (317.2162)


   

1-(2-(4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENOXY)ETHYL)PYRROLIDINE

1-(2-(4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENOXY)ETHYL)PYRROLIDINE

C18H28BNO3 (317.2162)


   

4-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenethyl)Morpholine

4-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenethyl)Morpholine

C18H28BNO3 (317.2162)


   

4-Hydroxysphinganine

4-Hydroxysphinganine

C18H39NO3 (317.293)


   

4,17alpha-Dimethyl-4-aza-5-androsten-17beta-ol-3-one

4,17alpha-Dimethyl-4-aza-5-androsten-17beta-ol-3-one

C20H31NO2 (317.2355)


   

Arachidonoyl-N-methyl amide

Arachidonoyl-N-methyl amide

C21H35NO (317.2719)


   

ent-7alpha-hydroxykaur-16-en-19-oate

ent-7alpha-hydroxykaur-16-en-19-oate

C20H29O3- (317.2117)


   

18R-hydroxy-eicosapentaenoate

18R-hydroxy-eicosapentaenoate

C20H29O3- (317.2117)


   

epi-leukotriene A4

epi-leukotriene A4

C20H29O3- (317.2117)


   
   

15-oxo-ETE(1-)

15-oxo-ETE(1-)

C20H29O3- (317.2117)


A polyunsaturated oxo fatty acid anion that is the conjugate base of 15-oxo-ETE.

   

(5Z,9E,11Z,14Z)-8-oxoicosa-5,9,11,14-tetraenoate

(5Z,9E,11Z,14Z)-8-oxoicosa-5,9,11,14-tetraenoate

C20H29O3- (317.2117)


   

12-oxo-ETE(1-)

12-oxo-ETE(1-)

C20H29O3- (317.2117)


A oxo fatty acid anion that is the conjugate base of 12-oxo-ETE, obtained by deprotonation of the carboxy group.

   

kauralexin A3

kauralexin A3

C20H29O3- (317.2117)


   

(11S,16S)-ent-kauran-11,16-epoxy-19-oate

(11S,16S)-ent-kauran-11,16-epoxy-19-oate

C20H29O3- (317.2117)


   

(8Z,11Z,14Z,17Z)-3-oxo-icosa-8,11,14,17-tetraenoate

(8Z,11Z,14Z,17Z)-3-oxo-icosa-8,11,14,17-tetraenoate

C20H29O3- (317.2117)


   

leukotriene A4(1-)

leukotriene A4(1-)

C20H29O3- (317.2117)


The leukotriene anion that is the conjugate base of leukotriene A4 arising from deprotonation of the carboxylic acid group. Major microspecies at pH 7.3.

   

5-oxo-ETE(1-)

5-oxo-ETE(1-)

C20H29O3- (317.2117)


A long-chain fatty acid anion that is the conjugate base of 5-oxo-ETE, obtained by deprotonation of the carboxy group.

   

15(R)-Hepe(1-)

15(R)-Hepe(1-)

C20H29O3- (317.2117)


An icosanoid anion that is the conjugate base of 15(R)-HEPE arising from deprotonation of the carboxylic acid group; major species at pH 7.3.

   

(5Z,8Z,11Z,14Z,16E)-18-hydroxyicosa-5,8,11,14,16-pentaenoate

(5Z,8Z,11Z,14Z,16E)-18-hydroxyicosa-5,8,11,14,16-pentaenoate

C20H29O3- (317.2117)


   

N-(p-octylbenzoyl)-piperidin-4-ol

N-(p-octylbenzoyl)-piperidin-4-ol

C20H31NO2 (317.2355)


   

D-xylo-Phytosphingosine

D-xylo-Phytosphingosine

C18H39NO3 (317.293)


   

20-Oxoarachidonate

20-Oxoarachidonate

C20H29O3- (317.2117)


A polyunsaturated fatty acid anion that is the conjugate base of 20-oxoarachidonic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

eoxin A4(1-)

eoxin A4(1-)

C20H29O3- (317.2117)


A polyunsaturated fatty acid anion that is the conjugate base of eoxin A4, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

17(S),18(R)-EETeTr(1-)

17(S),18(R)-EETeTr(1-)

C20H29O3- (317.2117)


A 17,18-EETeTr(1-) in which the epoxy group has (17S,18R)-configuration.

   

11-oxo-ETE(1-)

11-oxo-ETE(1-)

C20H29O3- (317.2117)


A polyunsaturated oxo fatty acid anion that is the conjugate base of 11-oxo-ETE, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

17,18-EETeTr(1-)

17,18-EETeTr(1-)

C20H29O3- (317.2117)


A polyunsaturated fatty acid anion that is the conjugate base of 17,18-EETeTr, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoate

(6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoate

C20H29O3- (317.2117)


   

(5Z,8Z,11Z,14Z,17Z)-20-hydroxyicosa-5,8,11,14,17-pentaenoate

(5Z,8Z,11Z,14Z,17Z)-20-hydroxyicosa-5,8,11,14,17-pentaenoate

C20H29O3- (317.2117)


   

11(R)-Hepe(1-)

11(R)-Hepe(1-)

C20H29O3- (317.2117)


An icosanoid anion that is the conjugate base of 11(R)-HEPE arising from deprotonation of the carboxylic acid group; major species at pH 7.3.

   

(5Z,8Z,11Z,14Z,17Z)-19-hydroxyicosa-5,8,11,14,17-pentaenoate

(5Z,8Z,11Z,14Z,17Z)-19-hydroxyicosa-5,8,11,14,17-pentaenoate

C20H29O3- (317.2117)


   

18(S)-Hepe(1-)

18(S)-Hepe(1-)

C20H29O3- (317.2117)


An 18-HEPE(1-) that is the conjugate base of 18(S)-HEPE, arising from deprotonation of the carboxylic acid group; major species at pH 7.3.

   

15(S)-Hepe(1-)

15(S)-Hepe(1-)

C20H29O3- (317.2117)


A HEPE(1-) that is the conjugate base of 15(S)-HEPE, arising from deprotonation of the carboxylic acid group; major species at pH 7.3.

   

17(R),18(S)-EETeTr(1-)

17(R),18(S)-EETeTr(1-)

C20H29O3- (317.2117)


A 17,18-EETeTr(1-) in which the epoxy group has (17R,18S)-configuration.

   

8,9-epoxy-(5Z,11Z,14Z,17Z)-eicosatetraenoate

8,9-epoxy-(5Z,11Z,14Z,17Z)-eicosatetraenoate

C20H29O3- (317.2117)


   

(5Z)-7-{(2R,3Z)-3-[(2Z,5Z)-undeca-2,5-dien-1-ylidene]oxiran-2-yl}hept-5-enoate

(5Z)-7-{(2R,3Z)-3-[(2Z,5Z)-undeca-2,5-dien-1-ylidene]oxiran-2-yl}hept-5-enoate

C20H29O3- (317.2117)


   

14,15-Epoxy-(5Z,8Z,11Z,17Z)-eicosatetraenoate

14,15-Epoxy-(5Z,8Z,11Z,17Z)-eicosatetraenoate

C20H29O3- (317.2117)


   

(5Z,8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoate

(5Z,8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoate

C20H29O3- (317.2117)


   

11,12-epoxy-(5Z,8Z,14Z,17Z)-eicosatetraenoate

11,12-epoxy-(5Z,8Z,14Z,17Z)-eicosatetraenoate

C20H29O3- (317.2117)


   

(5Z,7E,11Z,14Z)-9-oxoicosa-5,7,11,14-tetraenoate

(5Z,7E,11Z,14Z)-9-oxoicosa-5,7,11,14-tetraenoate

C20H29O3- (317.2117)


   

(5Z,7E,11Z,14Z,17Z)-9-hydroxyicosa-5,7,11,14,17-pentaenoate

(5Z,7E,11Z,14Z,17Z)-9-hydroxyicosa-5,7,11,14,17-pentaenoate

C20H29O3- (317.2117)


   

(2S)-2,6-bis[(3R)-3-aminobutanamido]hexanoate

(2S)-2,6-bis[(3R)-3-aminobutanamido]hexanoate

C14H29N4O4+ (317.2189)


   

4-Hydroxy-all-trans-13,14-dihydroretinoate

4-Hydroxy-all-trans-13,14-dihydroretinoate

C20H29O3- (317.2117)


   

12(S)-Hepe(1-)

12(S)-Hepe(1-)

C20H29O3- (317.2117)


   

5(S)-Hepe(1-)

5(S)-Hepe(1-)

C20H29O3- (317.2117)


   

(2R,7S,10S)-1-[(2R)-piperidin-2-yl]-3,15-diazatetracyclo[7.7.1.02,7.010,15]heptadecane

(2R,7S,10S)-1-[(2R)-piperidin-2-yl]-3,15-diazatetracyclo[7.7.1.02,7.010,15]heptadecane

C20H35N3 (317.2831)


   

(3Z,6Z,9Z,12Z,15Z)-N-(2-hydroxyethyl)octadeca-3,6,9,12,15-pentaenamide

(3Z,6Z,9Z,12Z,15Z)-N-(2-hydroxyethyl)octadeca-3,6,9,12,15-pentaenamide

C20H31NO2 (317.2355)


   

butenafine

butenafine

C23H27N (317.2143)


D - Dermatologicals > D01 - Antifungals for dermatological use > D01A - Antifungals for topical use D000890 - Anti-Infective Agents > D000935 - Antifungal Agents C254 - Anti-Infective Agent > C514 - Antifungal Agent

   

(-)-Ormosanine

(-)-Ormosanine

C20H35N3 (317.2831)


   

2-Amino-1,3,4-octadecanetriol

2-Amino-1,3,4-octadecanetriol

C18H39NO3 (317.293)


   

3-Hydroxynonanoylcarnitine

3-Hydroxynonanoylcarnitine

C16H31NO5 (317.2202)


   

19-HEPE(1-)

19-HEPE(1-)

C20H29O3 (317.2117)


A polyunsaturated fatty acid anion that is the conjugate base of 19-HEPE, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(5Z,11Z,14Z,17Z)-8,9-epoxyicosatetraenoate

(5Z,11Z,14Z,17Z)-8,9-epoxyicosatetraenoate

C20H29O3 (317.2117)


An EpETE(1-) that is the conjugate base of (5Z,11Z,14Z,17Z)-8,9-epoxyicosatetraenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(5Z,8R,9Z,11Z,14Z)-8,9-epoxyicosatetraenoate

(5Z,8R,9Z,11Z,14Z)-8,9-epoxyicosatetraenoate

C20H29O3 (317.2117)


An EpETE(1-) that is the conjugate base of (5Z,8R,9Z,11Z,14Z)-8,9-epoxyicosatetraenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

17beta-Hydroxy-4,17-dimethyl-4-azaandrost-5-en-3-one

17beta-Hydroxy-4,17-dimethyl-4-azaandrost-5-en-3-one

C20H31NO2 (317.2355)


   

9-HEPE(1-)

9-HEPE(1-)

C20H29O3 (317.2117)


A HEPE(1-) that is the conjugate base of 9-HEPE, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

8-oxo-ETE(1-)

8-oxo-ETE(1-)

C20H29O3 (317.2117)


An unsaturated fatty acid anion that is the conjugate base of 8-KETE, obtained by deprotonation of the carboxy group.

   

5-HEPE(1-)

5-HEPE(1-)

C20H29O3 (317.2117)


An icosanoid anion that is the conjugate base of 5-HEPE arising from deprotonation of the carboxylic acid function; major species at pH 7.3.

   

18(R)-HEPE(1-)

18(R)-HEPE(1-)

C20H29O3 (317.2117)


An icosanoid anion that is the conjugate base of 18(R)-HEPE arising from deprotonation of the carboxylic acid group; major species at pH 7.3.

   

18-HEPE(1-)

18-HEPE(1-)

C20H29O3 (317.2117)


An icosanoid anion that is the conjugate base of 18-HEPE, arising from deprotonation of the carboxylic acid group; major species at pH 7.3.

   

20-HEPE(1-)

20-HEPE(1-)

C20H29O3 (317.2117)


A polyunsaturated fatty acid anion that is the conjugate base of 20-HEPE, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

12-HEPE(1-)

12-HEPE(1-)

C20H29O3 (317.2117)


A HEPE(1-) that is the conjugate base of 12-HEPE, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(5Z,8Z,14Z,17Z)-11,12-epoxyicosatetraenoate

(5Z,8Z,14Z,17Z)-11,12-epoxyicosatetraenoate

C20H29O3 (317.2117)


An EpETE(1-) that is the conjugate base of (5Z,8Z,14Z,17Z)-11,12-epoxyicosatetraenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(5Z,8Z,11Z,17Z)-14,15-Epoxyicosatetraenoate

(5Z,8Z,11Z,17Z)-14,15-Epoxyicosatetraenoate

C20H29O3 (317.2117)


An EpETE(1-) that is the conjugate base of (5Z,8Z,11Z,17Z)-14,15-epoxyicosatetraenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

Sphingosine (t18:0)

SPH(t18:0)

C18H39NO3 (317.293)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   
   

mycalenitrile-17

mycalenitrile-17

C21H35NO (317.2719)


   

(1r,2r,7s,9r,10r)-1-[(2r)-piperidin-2-yl]-3,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecane

(1r,2r,7s,9r,10r)-1-[(2r)-piperidin-2-yl]-3,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecane

C20H35N3 (317.2831)


   

(2S, 3 S, 4R)-2-(sixteen carbon amido)- octadecane-1,3,4-triol

NA

C18H39NO3 (317.293)


{"Ingredient_id": "HBIN006707","Ingredient_name": "(2S, 3 S, 4R)-2-(sixteen carbon amido)- octadecane-1,3,4-triol","Alias": "NA","Ingredient_formula": "C18H39NO3","Ingredient_Smile": "CCCCCCCCCCCCCCC(C(C(CO)N)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "42986","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

aliphatic

NA

C17H39N3O2 (317.3042)


{"Ingredient_id": "HBIN015131","Ingredient_name": "aliphatic","Alias": "NA","Ingredient_formula": "C17H39N3O2","Ingredient_Smile": "CCCCCCCC(C)(C)OCC1CO1.C(CNCCN)N","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "33708","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

1-(piperidin-2-yl)-3,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecane

1-(piperidin-2-yl)-3,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecane

C20H35N3 (317.2831)


   

(1s,2s,7s,9r,10s)-1-[(2s)-piperidin-2-yl]-3,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecane

(1s,2s,7s,9r,10s)-1-[(2s)-piperidin-2-yl]-3,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecane

C20H35N3 (317.2831)


   

mycalenitrile-18

mycalenitrile-18

C21H35NO (317.2719)


   

(1s,2s,7s,9r,10s)-1-[(2r)-piperidin-2-yl]-3,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecane

(1s,2s,7s,9r,10s)-1-[(2r)-piperidin-2-yl]-3,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecane

C20H35N3 (317.2831)


   

1-[(1s,3as,3br,5as,7r,9ar,9br,11as)-7-amino-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-1-yl]ethanone

1-[(1s,3as,3br,5as,7r,9ar,9br,11as)-7-amino-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-1-yl]ethanone

C21H35NO (317.2719)


   

(1s,3as,3br,5as,9as,9bs,11as)-1-[(1s)-1-aminoethyl]-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthren-7-one

(1s,3as,3br,5as,9as,9bs,11as)-1-[(1s)-1-aminoethyl]-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthren-7-one

C21H35NO (317.2719)


   

(2r)-2-[9-(2-methoxyphenyl)nonyl]-1-methylpyrrolidine

(2r)-2-[9-(2-methoxyphenyl)nonyl]-1-methylpyrrolidine

C21H35NO (317.2719)


   

(1s,2s,7r,9s,10r)-1-[(2s)-piperidin-2-yl]-3,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecane

(1s,2s,7r,9s,10r)-1-[(2s)-piperidin-2-yl]-3,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecane

C20H35N3 (317.2831)


   

1-hydroxy-4,5,8-trimethyl-3-(2-methylpropyl)-3h,3ah,4h,6ah,7h,8h,9h,10h-cyclohepta[d]isoindol-11-one

1-hydroxy-4,5,8-trimethyl-3-(2-methylpropyl)-3h,3ah,4h,6ah,7h,8h,9h,10h-cyclohepta[d]isoindol-11-one

C20H31NO2 (317.2355)


   

(2r,7s,10s)-1-[(2r)-piperidin-2-yl]-3,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecane

(2r,7s,10s)-1-[(2r)-piperidin-2-yl]-3,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecane

C20H35N3 (317.2831)


   

(7r)-1-[(2s)-piperidin-2-yl]-3,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecane

(7r)-1-[(2s)-piperidin-2-yl]-3,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecane

C20H35N3 (317.2831)


   

1-(1-aminoethyl)-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthren-7-one

1-(1-aminoethyl)-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthren-7-one

C21H35NO (317.2719)


   

(7as,11as,11bs)-4-(2-hydroxypropan-2-yl)-8,8,11a-trimethyl-6h,7h,7ah,9h,10h,11h-naphtho[1,2-d]azepin-11b-ol

(7as,11as,11bs)-4-(2-hydroxypropan-2-yl)-8,8,11a-trimethyl-6h,7h,7ah,9h,10h,11h-naphtho[1,2-d]azepin-11b-ol

C20H31NO2 (317.2355)


   

(1s,3as,5as,9as,9bs,11as)-1-[(1s)-1-aminoethyl]-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthren-7-one

(1s,3as,5as,9as,9bs,11as)-1-[(1s)-1-aminoethyl]-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthren-7-one

C21H35NO (317.2719)


   

(2e,4e,9e,12e)-n-(2-methylbutyl)hexadeca-2,4,9,12-tetraenimidic acid

(2e,4e,9e,12e)-n-(2-methylbutyl)hexadeca-2,4,9,12-tetraenimidic acid

C21H35NO (317.2719)


   

(1s,2s,7s,9r,10r)-1-[(2r)-piperidin-2-yl]-3,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecane

(1s,2s,7s,9r,10r)-1-[(2r)-piperidin-2-yl]-3,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecane

C20H35N3 (317.2831)


   

(1s,10r)-10-heptyl-6-methyl-7,9,12-triazatricyclo[6.3.1.0⁴,¹²]dodeca-4,6,8-triene-5-carboxylic acid

(1s,10r)-10-heptyl-6-methyl-7,9,12-triazatricyclo[6.3.1.0⁴,¹²]dodeca-4,6,8-triene-5-carboxylic acid

C18H27N3O2 (317.2103)


   

4-(2-hydroxypropan-2-yl)-8,8,11a-trimethyl-6h,7h,7ah,9h,10h,11h-naphtho[1,2-d]azepin-11b-ol

4-(2-hydroxypropan-2-yl)-8,8,11a-trimethyl-6h,7h,7ah,9h,10h,11h-naphtho[1,2-d]azepin-11b-ol

C20H31NO2 (317.2355)


   

(1s,2r,7r,9r,10r)-1-[(2s)-piperidin-2-yl]-3,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecane

(1s,2r,7r,9r,10r)-1-[(2s)-piperidin-2-yl]-3,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecane

C20H35N3 (317.2831)


   

(1s,2s,7r,9r,10s)-1-[(2s)-piperidin-2-yl]-3,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecane

(1s,2s,7r,9r,10s)-1-[(2s)-piperidin-2-yl]-3,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecane

C20H35N3 (317.2831)


   

(2s,3s,6r)-2-benzyl-1-methyl-6-octylpiperidin-3-ol

(2s,3s,6r)-2-benzyl-1-methyl-6-octylpiperidin-3-ol

C21H35NO (317.2719)


   

(2r,3s,4s,6s)-2-(hydroxymethyl)-6-(2-hydroxyundecyl)piperidine-3,4-diol

(2r,3s,4s,6s)-2-(hydroxymethyl)-6-(2-hydroxyundecyl)piperidine-3,4-diol

C17H35NO4 (317.2566)


   

(2r,7s,9s,10r)-1-[(2r)-piperidin-2-yl]-3,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecane

(2r,7s,9s,10r)-1-[(2r)-piperidin-2-yl]-3,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecane

C20H35N3 (317.2831)


   

(1s,2s,7r,9r,10r)-1-[(2s)-piperidin-2-yl]-3,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecane

(1s,2s,7r,9r,10r)-1-[(2s)-piperidin-2-yl]-3,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecane

C20H35N3 (317.2831)


   

(1s,2r,7r,9s,10r)-1-[(2s)-piperidin-2-yl]-3,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecane

(1s,2r,7r,9s,10r)-1-[(2s)-piperidin-2-yl]-3,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecane

C20H35N3 (317.2831)


   

(2r,3r,6s)-2-methyl-6-(9-phenylnonyl)piperidin-3-ol

(2r,3r,6s)-2-methyl-6-(9-phenylnonyl)piperidin-3-ol

C21H35NO (317.2719)


   

(1s,2r,7r,9r,10s)-1-[(2r)-piperidin-2-yl]-3,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecane

(1s,2r,7r,9r,10s)-1-[(2r)-piperidin-2-yl]-3,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecane

C20H35N3 (317.2831)


   

(3s,3ar,4s,6as,8s,11ar)-1-hydroxy-4,5,8-trimethyl-3-(2-methylpropyl)-3h,3ah,4h,6ah,7h,8h,9h,10h-cyclohepta[d]isoindol-11-one

(3s,3ar,4s,6as,8s,11ar)-1-hydroxy-4,5,8-trimethyl-3-(2-methylpropyl)-3h,3ah,4h,6ah,7h,8h,9h,10h-cyclohepta[d]isoindol-11-one

C20H31NO2 (317.2355)